C12N 2770/10021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/10021 (Viruses as such) appears on 73 US grants and 68 published applications in this corpus.
Search patents in C12N- Granted patents
- 73
- Published applications
- 68
- Assignees
- 42
- Inventors
- 143
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 1 |
| 2002 | 4 | 2 |
| 2003 | 1 | 7 |
| 2004 | 2 | 1 |
| 2005 | 3 | 3 |
| 2006 | 1 | 2 |
| 2007 | 6 | 2 |
| 2008 | 1 | 3 |
| 2009 | 2 | 0 |
| 2010 | 0 | 4 |
| 2011 | 2 | 1 |
| 2012 | 2 | 4 |
| 2013 | 1 | 1 |
| 2014 | 3 | 6 |
| 2015 | 4 | 4 |
| 2016 | 4 | 4 |
| 2017 | 3 | 6 |
| 2018 | 6 | 3 |
| 2019 | 3 | 5 |
| 2020 | 5 | 2 |
| 2021 | 2 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant arterivirus replicon systems and uses thereof4 Nov 2025US 12,460,229 B2Janssen Pharmaceuticals, Inc.
- Porcine Reproductive and Respiratory Syndrome vaccine virus4 Feb 2025US 12,214,032 B2Elanco UK AH Limited
- Recombinant arterivirus replicon systems and uses thereof17 Jan 2023US 11,555,205 B2Janssen Pharmaceuticals, Inc.
- Porcine reproductive and respiratory syndrome virus cDNA clone and uses thereof17 May 2022US 11,332,739 B2Consejo Superior De Investigaciones Cientificas (Csic)
- Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using5 Oct 2021US 11,136,355 B2NUtech Ventures
- Methods and compositions for vaccinating piglets against prrs-1 virus9 Jul 2026US 2026/0191945 A1Zoetis Services LLC
- Nadc34-like prrsv-2 vaccine candidate strain and application thereof2 Apr 2026US 2026/0091100 A1Yangzhou University
- Methods for predicting efficacy of a modified live porcine reproductive and respiratory syndrome virus (prrsv) vaccine28 Aug 2025US 2025/0269006 A1Elanco US Inc.
- Porcine reproductive and respiratory syndrome vaccine virus24 Apr 2025US 2025/0127876 A1Elanco UK AH Limited
- Long-term surrogate virus assays and methods21 Nov 2024US 2024/0384361 A1Regents of the University of Minnesota
Most cited
By later US patents
- Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome71US 5,695,766 AIowa State University Research Foundation, Inc. · 1997
- Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits63US 5,620,691 AStichting Centraal Diergeneeskundig Instituut · 1997
- Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof55US 6,500,662 B1Pfizer Inc. · 2002
- Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof55US 6,841,364 B2ProtaTek International, Inc. · 2005
- Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof54US 7,273,617 B2ProtaTek International, Inc. · 2007